PT115583B - Processo contínuo para a preparação de medicamentos anticolinérgicos - Google Patents

Processo contínuo para a preparação de medicamentos anticolinérgicos Download PDF

Info

Publication number
PT115583B
PT115583B PT115583A PT11558319A PT115583B PT 115583 B PT115583 B PT 115583B PT 115583 A PT115583 A PT 115583A PT 11558319 A PT11558319 A PT 11558319A PT 115583 B PT115583 B PT 115583B
Authority
PT
Portugal
Prior art keywords
bromide
preparation
continuous process
anticholinergic drugs
anticholinergic
Prior art date
Application number
PT115583A
Other languages
English (en)
Portuguese (pt)
Other versions
PT115583A (pt
Inventor
Katz Marianna
Torres Lourenço Nuno
Original Assignee
Hovione Farm S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=71120199&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT115583(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hovione Farm S A filed Critical Hovione Farm S A
Priority to PT115583A priority Critical patent/PT115583B/pt
Priority to JP2021574905A priority patent/JP2022549545A/ja
Priority to CA3141271A priority patent/CA3141271A1/en
Priority to CN202080049646.2A priority patent/CN114206863A/zh
Priority to PCT/GB2020/051448 priority patent/WO2020254791A1/en
Priority to EP20734291.6A priority patent/EP3982923B1/en
Priority to US17/617,725 priority patent/US20220251078A1/en
Priority to KR1020227000471A priority patent/KR20220024433A/ko
Priority to AU2020296972A priority patent/AU2020296972B2/en
Publication of PT115583A publication Critical patent/PT115583A/pt
Priority to IL288972A priority patent/IL288972A/en
Publication of PT115583B publication Critical patent/PT115583B/pt
Priority to JP2025025794A priority patent/JP2025081547A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT115583A 2019-06-17 2019-06-17 Processo contínuo para a preparação de medicamentos anticolinérgicos PT115583B (pt)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PT115583A PT115583B (pt) 2019-06-17 2019-06-17 Processo contínuo para a preparação de medicamentos anticolinérgicos
AU2020296972A AU2020296972B2 (en) 2019-06-17 2020-06-16 Continuous process for the preparation of anticholinergic drugs
PCT/GB2020/051448 WO2020254791A1 (en) 2019-06-17 2020-06-16 Continuous process for the preparation of anticholinergic drugs
CA3141271A CA3141271A1 (en) 2019-06-17 2020-06-16 Continuous process for the preparation of anticholinergic drugs
CN202080049646.2A CN114206863A (zh) 2019-06-17 2020-06-16 制备抗胆碱药的连续方法
JP2021574905A JP2022549545A (ja) 2019-06-17 2020-06-16 抗コリン薬の調製のための連続プロセス
EP20734291.6A EP3982923B1 (en) 2019-06-17 2020-06-16 Continuous process for the preparation of anticholinergic drugs
US17/617,725 US20220251078A1 (en) 2019-06-17 2020-06-16 Continuous Process for the Preparation of Anticholinergic Drugs
KR1020227000471A KR20220024433A (ko) 2019-06-17 2020-06-16 항콜린 약물의 연속 제조방법
IL288972A IL288972A (en) 2019-06-17 2021-12-13 A continuous process for the preparation of anticholinergic drugs
JP2025025794A JP2025081547A (ja) 2019-06-17 2025-02-20 抗コリン薬の調製のための連続方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT115583A PT115583B (pt) 2019-06-17 2019-06-17 Processo contínuo para a preparação de medicamentos anticolinérgicos

Publications (2)

Publication Number Publication Date
PT115583A PT115583A (pt) 2021-06-03
PT115583B true PT115583B (pt) 2022-05-02

Family

ID=71120199

Family Applications (1)

Application Number Title Priority Date Filing Date
PT115583A PT115583B (pt) 2019-06-17 2019-06-17 Processo contínuo para a preparação de medicamentos anticolinérgicos

Country Status (10)

Country Link
US (1) US20220251078A1 (cg-RX-API-DMAC7.html)
EP (1) EP3982923B1 (cg-RX-API-DMAC7.html)
JP (2) JP2022549545A (cg-RX-API-DMAC7.html)
KR (1) KR20220024433A (cg-RX-API-DMAC7.html)
CN (1) CN114206863A (cg-RX-API-DMAC7.html)
AU (1) AU2020296972B2 (cg-RX-API-DMAC7.html)
CA (1) CA3141271A1 (cg-RX-API-DMAC7.html)
IL (1) IL288972A (cg-RX-API-DMAC7.html)
PT (1) PT115583B (cg-RX-API-DMAC7.html)
WO (1) WO2020254791A1 (cg-RX-API-DMAC7.html)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
AR050902A1 (es) 2004-04-27 2006-12-06 Glaxo Group Ltd Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
KR20080012932A (ko) 2005-05-02 2008-02-12 베링거 인겔하임 인터내셔날 게엠베하 티오트로퓸 브로마이드의 신규한 결정형
EP1879888A2 (en) 2005-05-02 2008-01-23 Boehringer Ingelheim International GmbH Crystalline forms of tiotropium bromide
RU2453547C2 (ru) 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
PT1869035E (pt) 2005-12-19 2013-01-10 Sicor Inc Novas formas de brometo de tiotrópio e processos para sua preparação
JP5333342B2 (ja) 2009-06-29 2013-11-06 株式会社デンソー 半導体装置
ES2625498T3 (es) * 2011-12-22 2017-07-19 Cerbios-Pharma S.A. Proceso continuo para la alquilación de aminas terciarias cíclicas
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
JP6389174B2 (ja) 2012-08-15 2018-09-12 グラクソ グループ リミテッドGlaxo Group Limited 化学的方法
CZ27764U1 (cs) 2014-08-22 2015-02-02 Zentiva, K.S. uMethanolový solvát umeclidinium bromidu
PT108370B (pt) * 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
EP3248970A1 (en) 2016-05-27 2017-11-29 Zentiva K.S. Forms of umeclidinium bromide
PT109740B (pt) * 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio

Also Published As

Publication number Publication date
EP3982923C0 (en) 2024-05-15
KR20220024433A (ko) 2022-03-03
US20220251078A1 (en) 2022-08-11
EP3982923A1 (en) 2022-04-20
PT115583A (pt) 2021-06-03
AU2020296972B2 (en) 2025-04-24
EP3982923B1 (en) 2024-05-15
CN114206863A (zh) 2022-03-18
WO2020254791A1 (en) 2020-12-24
IL288972A (en) 2022-02-01
JP2025081547A (ja) 2025-05-27
JP2022549545A (ja) 2022-11-28
AU2020296972A1 (en) 2022-01-20
CA3141271A1 (en) 2020-12-24

Similar Documents

Publication Publication Date Title
BR112015006571A2 (pt) composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados
MX2018000688A (es) Triciclicos sustituidos y metodo para usarlos.
CA2897464C (en) Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
UY35963A (es) Determinadas (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1
BR112018007161A2 (pt) pirazolo[3,4-b]piridin-6-carboxamidas n-sulfoniladas e métodos de uso
CL2014000122A1 (es) Compuestos derivados de indazol, inhibidores de janus quinasa (jak); composicion farmaceutica que los comprende; y su uso para tratar rinitis alergica, congestion nasal, asma, bronquitis cronica, artritis, insuficiencia cardiaca, colitis ulcerativa, infeccion viral y bacteriana, cancer y alzheimer, entre otras enfermedades.
BR112017020039A2 (pt) composição farmacêutica, kit, método, processo para preparar uma composição e solução farmacêutica
BR112018007145A2 (pt) ácidos pirazolo[3,4-b]piridin-6-carboxílicos substituídos e o seu uso
MX2019007135A (es) Derivados de heteroarilo biciclico como potenciadores de cftr.
BR112015028964A2 (pt) composição de suspensão, e, método para tratar uma doença ou um distúrbio pulmonar
TW200708513A (en) Novel crystalline forms of tiotropium bromide
EA201190108A1 (ru) Фармацевтическая композиция для ингаляции
WO2006117300A3 (en) Crystalline forms of tiotropium bromide
EA201590030A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
EA201290374A1 (ru) Аэрозольная композиция для copd
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
EA201590019A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
BR112017013999A2 (pt) ?composição derivada de uma bifidobactéria?
PE20170073A1 (es) Combinaciones de bromuro de tiotropio, formoterol y budesonida para el tratamiento de la copd
ECSP066545A (es) Procedimiento para la preparación de sales de tiotropio, sales de tiotropio, así como formulaciones medicamentosas que las contienen
EA201590036A1 (ru) Композиции для ингалятора сухого порошка, содержащие антагонисты мускариновых рецепторов длительного действия
BR112016002222A2 (pt) partículas inaláveis compreendendo tiotrópio e indacaterol
PT115583A (pt) Processo contínuo para a preparação de medicamentos anticolinérgicos
EA029678B9 (ru) Четвертичные соли пиперидиния
ECSP055821A (es) Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20210531

FG3A Patent granted, date of granting

Effective date: 20220427